Literature DB >> 29730946

[Adverse effects of long-term proton-pump inhibitor therapy on adults].

Iván Igaz1, Gábor Simonyi2, Sándor Balogh3, Miklós Szathmári1.   

Abstract

In the last few decades, proton-pump inhibitors have become the mainstay of the treatment of acid-related disorders. Despite their efficacy, these drugs are not without risks. Recently several articles have been published on their long-term adverse effects. Among these adverse effects, the higher risk of bone fractures, the vitamin B12 and magnesium deficiencies and the higher risk of Clostridium difficile infection may be relevant. As these drugs are prescribed more and more frequently all over the world, the knowledge of the long-term adverse effects is very important not only for the specialists but for the general practitioners as well. In this review, the authors discuss the recent findings in this field, emphasising that the long-term use of these drugs must be based on an adequate and strong indication. Orv Hetil. 2018; 159(19): 735-740.

Entities:  

Keywords:  Clostridium difficile; dementia; osteoporosis; pneumonia; proton pump inhibitor; protonpumpagátló; tüdőgyulladás

Mesh:

Substances:

Year:  2018        PMID: 29730946     DOI: 10.1556/650.2018.31057

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  4 in total

1.  Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics.

Authors:  Mária Matuz; Ria Benkő; Zsófia Engi; Krisztina Schváb; Péter Doró; Réka Viola; Mária Szabó; Gyöngyvér Soós
Journal:  Front Pharmacol       Date:  2020-09-08       Impact factor: 5.810

2.  New treatment for gastroesophageal reflux disease: Traditional Chinese medicine Xiaochaihu decoction.

Authors:  Li-Ying Xu; Bin-Yan Yu; Lu-Sha Cen
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

3.  Association between hospital-acquired pneumonia and proton pump inhibitor prophylaxis in patients treated with glucocorticoids: a retrospective cohort study based on 307,622 admissions in China.

Authors:  Xufeng Mao; Zhangwei Yang
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

Review 4.  The Use of Proton Pump Inhibitors May Increase Symptoms of Muscle Function Loss in Patients with Chronic Illnesses.

Authors:  Paulien Vinke; Evertine Wesselink; Wout van Orten-Luiten; Klaske van Norren
Journal:  Int J Mol Sci       Date:  2020-01-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.